{"name": "Cytochroma",
 "permalink": "cytochroma",
 "crunchbase_url": "http://www.crunchbase.com/company/cytochroma",
 "homepage_url": "http://www.cytochroma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "847-236-7707",
 "description": "",
 "created_at": "Thu Jan 10 13:11:43 UTC 2013",
 "updated_at": "Thu Jan 10 13:31:07 UTC 2013",
 "overview": "\u003Cp\u003ECytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). The Company has an advanced portfolio of new therapies designed to safely and effectively treat patients with vitamin D insufficiency and SHPT associated with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       51],
      "assets/images/resized/0022/9040/229040v1-max-150x150.jpg"],
     [[250,
       85],
      "assets/images/resized/0022/9040/229040v1-max-250x250.jpg"],
     [[257,
       88],
      "assets/images/resized/0022/9040/229040v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": null,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.prnewswire.com/news-releases/opko-health-to-acquire-privately-held-cytochroma-186088892.html",
   "source_description": "OPKO Health to acquire privately held Cytochroma",
   "acquired_year": 2013,
   "acquired_month": 1,
   "acquired_day": 8,
   "acquiring_company":
    {"name": "OPKO Health",
     "permalink": "opko-health",
     "image":
      {"available_sizes":
        [[[150,
           29],
          "assets/images/resized/0005/9178/59178v1-max-150x150.jpg"],
         [[150,
           29],
          "assets/images/resized/0005/9178/59178v1-max-250x250.jpg"],
         [[150,
           29],
          "assets/images/resized/0005/9178/59178v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "2333 Waukegan Road",
    "address2": "Suite E100",
    "zip_code": "60015",
    "city": "Bannockburn",
    "state_code": "IL",
    "country_code": "USA",
    "latitude": 42.195691,
    "longitude": -87.859318}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}